Craft

Perrigo

Stock Price

$26.4

2024-10-29

Market Capitalization

$3.6 B

2024-10-29

Revenue

$4.3 B

FY, 2025

Perrigo Summary

Company Summary

Overview
Perrigo is an over-the-counter (OTC) consumer goods and pharmaceutical company. It offers pain relievers, fever reducers and sleep-aids, cough suppressants, expectorants, antacids, anti-diarrheal, and anti-heartburn products, infant formulas and nutritional beverages, dermatological care, scar management, lice treatment, and other products for various skin conditions, toothbrushes, toothbrush replacement heads, floss, flosser, and other self-care products. Its products sold under brand names include Prevacid24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees. The company serves retailers, pharmacies, and e-commerce channels.
Type
Public
Status
Active
Founded
1887
HQ
Dublin, IE | view all locations
Website
https://www.perrigo.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • James E. Dillard

    James E. Dillard, Executive Vice President & President, Consumer Self-Care Americas

  • Ron Janish

    Ron Janish, Executive Vice President of Global Operations and Supply Chain

  • Rob Willis

    Rob Willis, Executive Vice President & Chief Human Resources Officer

  • Eduardo Bezerra

    Eduardo Bezerra, Executive Vice President and Chief Financial Officer

LocationsView all

16 locations detected

  • Dublin, County Dublin HQ

    Ireland

    The Sharp Building Hogan Place

  • Allegan, MI

    United States

    515 Eastern Ave

  • Hørsholm

    Denmark

    Slotsmarken 18

  • Espoo

    Finland

    Lars Sonckin kaari 10

  • Ambernath, MH

    India

    Plot no. N/39/ 1; Anand Nagar; Additional M.I.D.C.

  • Mumbai, MH

    India

    211, Rupa Solitaire Millennium Business Park Plot No. A-1 MIDC Mahape

and 10 others

Perrigo Financials

Summary Financials

Revenue (Q1, 2026)
$969.2M
Gross profit (Q1, 2026)
$325.5M
Net income (Q1, 2026)
($398.6M)
Cash (Q1, 2026)
$357.2M
EBIT (Q1, 2026)
($372.3M)
Enterprise value
$6.9B

Footer menu